131 related articles for article (PubMed ID: 6840620)
21. [A syndrome of watery diarrhea, hypokalemia and hypochlorhydria caused by vasoactive-intestinal-polypeptide producing tumor (author's transl)].
Kawanaka M; Ohiwa N; Toyooka K; Matsuoka T; Mori T; Kakishita E; Nagai K; Yamaguchi K; Abe K; Kameya T
Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1546-54. PubMed ID: 744898
[No Abstract] [Full Text] [Related]
22. [Coeliac sprue and gut hormones: pathophysiological and clinical aspects (author's transl)].
Domschke S; Bloom SR; Domschke W; Demling L
Z Gastroenterol; 1981 Dec; 19(12):756-66. PubMed ID: 7034387
[TBL] [Abstract][Full Text] [Related]
23. Evidence for secretion of vasoactive intestinal peptide by tumours of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept.
Said SI
Clin Endocrinol (Oxf); 1976; 5 Suppl():201S-204S. PubMed ID: 29733
[TBL] [Abstract][Full Text] [Related]
24. Carcinoid APUDoma of the pancreas.
Cholankeril JV; McHugh WJ; Ketyer S; Giardina AC
Cardiovasc Intervent Radiol; 1981; 4(1):51-5. PubMed ID: 7018687
[TBL] [Abstract][Full Text] [Related]
25. PreproVIP-derived peptides in tissue and plasma from patients with VIP-producing tumours.
Rønnov-Jensen D; Gether U; Fahrenkrug J
Eur J Clin Invest; 1991 Apr; 21(2):154-60. PubMed ID: 1647952
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal hormones and cell proliferation.
Townsend CM; Bold RJ; Ishizuka J
Surg Today; 1994; 24(9):772-7. PubMed ID: 7865952
[TBL] [Abstract][Full Text] [Related]
27. Clinically silent gross hypergastrinaemia from a multiple hormone-secreting pancreatic apudoma.
Joffe SN; Elias E; Rehfeld JF; Polak JM; Bloom SR; Welbourn RB
Br J Surg; 1978 Apr; 65(4):277-80. PubMed ID: 205304
[TBL] [Abstract][Full Text] [Related]
28. Watery diarrhoea with a vasoactive intestinal peptide-producing ganglioneuroblastoma.
Iida Y; Nose O; Kai H; Okada A; Mori T; Lee PK; Kakudo K; Yanaihara N
Arch Dis Child; 1980 Dec; 55(12):929-36. PubMed ID: 7006519
[TBL] [Abstract][Full Text] [Related]
29. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
Domschke S; Domschke W; Bloom SR; Mitznegg P; Mitchell SJ; Lux G; Strunz U
Gut; 1978 Nov; 19(11):1049-53. PubMed ID: 730072
[TBL] [Abstract][Full Text] [Related]
30. [Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].
Bataille D; Peillon F; Besson J; Rosselin G
C R Seances Acad Sci D; 1979 May; 288(17):1315-7. PubMed ID: 225051
[TBL] [Abstract][Full Text] [Related]
31. [Pancreatic vipoma with bizarre characteristics].
Bermejo F; Moreno L; Moreira V; Gisbert JP; González Palacios F; García López JL
Gastroenterol Hepatol; 1999 Mar; 22(3):132-5. PubMed ID: 10228323
[TBL] [Abstract][Full Text] [Related]
32. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
Flückiger A; Schlup P
Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
[TBL] [Abstract][Full Text] [Related]
33. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
[TBL] [Abstract][Full Text] [Related]
34. Gastroenteropancreatic endocrine tumors.
Weil C
Klin Wochenschr; 1985 May; 63(10):433-59. PubMed ID: 2861306
[No Abstract] [Full Text] [Related]
35. Vasocative intestinal polypeptide (VIP)-producing ganglioneuroma in a child with chronic diarrhea.
Hansen LP; Lund HT; Fahrenkrug J; Søgaard H
Acta Paediatr Scand; 1980 May; 69(3):419-24. PubMed ID: 7376870
[TBL] [Abstract][Full Text] [Related]
36. Effect of soya bean oil on symptoms, gastric emptying and gut hormone release in patients with postvagotomy symptoms.
Lawaetz O; Bloom SR; Stimpel H; Siemssen OJ
Ann Chir Gynaecol; 1986; 75(6):308-13. PubMed ID: 3555275
[TBL] [Abstract][Full Text] [Related]
37. A renal vipoma.
Hamilton I; Reis L; Bilimoria S; Long RG
Br Med J; 1980 Nov; 281(6251):1323-4. PubMed ID: 7437784
[No Abstract] [Full Text] [Related]
38. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
39. Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.
Virgolini I; Kurtaran A; Leimer M; Kaserer K; Peck-Radosavljevic M; Angelberger P; Hübsch P; Dvorak M; Valent P; Niederle B
J Nucl Med; 1998 Sep; 39(9):1575-9. PubMed ID: 9744346
[TBL] [Abstract][Full Text] [Related]
40. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
